Catalyst Wire Dossier Catalyst Wire Dossier

Cyclosporine A ophthalmic solution 0.05%

Cyclosporine A · Allergan
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cyclosporine A ophthalmic solution 0.05%, covering 2017-03-28 to 2017-03-28. Get the full timeline:

Most recent: Clinical Trial Update: The Prophylactic Use of Topical Cyclosporine A 0.05% to Prevent Graft Versus Host Disease Related Dry Eye [Phase 4]

See pricing